Q4 2022 Arcturus Therapeutics Holdings Inc Earnings Call Transcript
Greetings, and welcome to Arcturus Therapeutics Fourth Quarter 2022 Financial Update and Pipeline Progress Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing. You may begin.
Thank you, operator. Good afternoon, and welcome to Arcturus Therapeutics Fourth Quarter 2022 Financial Update and Pipeline Progress call. Today's call will be led by Joseph Payne, our President and CEO; and Andy Sassine, our CFO; Dr. Pad Chivukula, our CSO and COO, will join in for the Q&A session as well.
Before we begin, I would like to remind everyone that the statements made during this call regarding matters that are not historical facts are forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |